© 2024 MJH Life Sciences™ and Patient Care Online. All rights reserved.
Grace Halsey
Articles
Awareness of Uncontrolled Hypertension Low, Particularly Among Young Adults, Study Warns
September 13, 2024
Unawareness was highest among the youngest adults, aged 18 to 44 years, an age range where CV health should be optimized to avoid later morbidity, researchers wrote.
How to Define an Atopic Dermatitis Flare: Survey Seeks New Patient Consensus
September 12, 2024
The term "flare" is used consistently in discussions of AD, but is everyone talking about the same thing? New research closes in on a patient-centered definition.
GSK mRNA Flu Vaccine Candidate Delivers Favorable Topline Phase 2 Findings, Ready for Phase 3
September 12, 2024
The GSK reformulation induced acceptable immune responses for both influenza A and B strains, overcoming a setback earlier in the ability to successfully neutralize the latter.
sNDA Goes to FDA for neffy 1 mg for Young Children with Type 1 Allergic Reactions
September 11, 2024
The needle-free nasal spray, if approved, would be the first new administration method for epinephrine in young children in 35 years.
Congenital Adrenal Hyperplasia Management Across the Lifespan
September 11, 2024
The cortisol deficiency central to congenital adrenal hyperplasia requires lifelong treatment with distinct shifts in management required at each developmental stage.
RSV Vaccine Proves 75% Effective Against Hospitalization in Older Adults, According to New CDC Data
September 10, 2024
The new data amend that from prelicensure trials, which did not include fair representation of older adults and others more vulnerable to severe RSV disease.
Novel GLP-1 RA for Obesity Shows Promise in Early Phase 1 Trial
September 09, 2024
Once-daily oral TERNS-601 was associated with a significant mean 5% weight reduction after 28 days and had a favorable tolerability profile.
CDC COVID-19 Vaccine Bridge Access Program Ends 4 Months Earlier than Planned
September 09, 2024
The Bridge Access Program allowed Americans who are uninsured or underinsured to receive COVID-19 vaccination at not cost and was ended abruptly last month.
Efsitora Alfa, Eli Lilly’s Once Weekly Insulin, Has Positive Topline Results in Two Trials
September 06, 2024
Across two clinical trials in the QWINT program, once-wekly efsitora showed comparable A1C reduction to frequently used daily insulins.
The CRF Pathway Interrupted: Potential to Transform CAH Care
September 03, 2024
A therapeutic strategy that reduces ACTH-driven androgen excess through a glucocorticoid-independent pathway could significantly improve treatment and patient QoL.